✦ LIBER ✦

Treatment optimisation in multiple sclerosis

✍ Scribed by M. Zaffaroni

Publisher: Springer Milan
Year: 2005
Tongue: English
Weight: 73 KB
Volume: 26
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-005-0513-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The way forward to treatment optimisatio

The way forward to treatment optimisation in multiple sclerosis

📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 80 KB

Is there or is there not a place for ant

Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?

✍ N. Grigoriadis; G. Deretzi; N. Artemis; N. Tascos; I. Milonas 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 38 KB

Multiple sclerosis: Symptomatic treatmen

Multiple sclerosis: Symptomatic treatment

✍ A. J. Thompson 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 791 KB

Immunomodulatory treatment strategies in

Immunomodulatory treatment strategies in multiple sclerosis

✍ Bernd C. Kieseier; Heinz Wiendl; Verena I. Leussink; Olaf Stüve 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 171 KB

Intrathecal methotrexate treatment in mu

Intrathecal methotrexate treatment in multiple sclerosis

✍ Saud A. Sadiq; Elena V. Simon; Lauren M. Puccio 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 172 KB

Immunological treatment of multiple scle

Immunological treatment of multiple sclerosis

✍ Richard A. C. Hughes 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 494 KB

Immunosuppressive treatment of multiple sclerosis (MS) is based on the autoimmune hypothesis for which the main evidence is the close histological similarity between the human disease and chronic relapsing EAE. Although controlled trials indicate that ACTH is effective in accelerating recovery from